Where previous research showed that PSMA therapy for prostate cancer can prolong the lives of patients who have exhausted all other treatment options, a new study now demonstrates that the therapy is also effective in an earlier stage of the disease. As a result, more burdensome hormone therapy can be postponed by twenty additional months, shows research led by Radboudumc.
Each year, approximately 15,000 men in the Netherlands are diagnosed with prostate cancer. Various treatments exist for this condition, including radiation, hormone therapy, and chemotherapy. A new treatment is irradiating the tumor from within using lightly radioactive PSMA. This therapy shows positive effects in about two out of three patients who have no remaining treatment options:…